Mesa Laboratories (MLAB) Stock Forecast, Price Target & Predictions
MLAB Stock Forecast
Mesa Laboratories stock forecast is as follows: an average price target of $120.00 (represents a -8.57% downside from MLAB’s last price of $131.25) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
MLAB Price Target
The average price target for Mesa Laboratories (MLAB) is $120.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $120.00 to $120.00. This represents a potential -8.57% downside from MLAB's last price of $131.25.
MLAB Analyst Ratings
According to 2 Wall Street analysts, Mesa Laboratories's rating consensus is 'Buy'. The analyst rating breakdown for MLAB stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 0 'Hold' (0.00%), 1 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).
Mesa Laboratories Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 27, 2024 | Brandon Couillard | Wells Fargo | $120.00 | $140.86 | -14.81% | -8.57% |
| Jun 07, 2024 | Vijay Kumar | Evercore ISI | $120.00 | $104.80 | 14.50% | -8.57% |
The latest Mesa Laboratories stock forecast, released on Aug 27, 2024 by Brandon Couillard from Wells Fargo, set a price target of $120.00, which represents a -14.81% decrease from the stock price at the time of the forecast ($140.86), and a -8.57% decrease from MLAB last price ($131.25).
Mesa Laboratories Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $120.00 |
| Last Closing Price | $131.25 | $131.25 | $131.25 |
| Upside/Downside | -100.00% | -100.00% | -8.57% |
In the current month, the average price target of Mesa Laboratories stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Mesa Laboratories's last price of $131.25. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 01, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Aug 27, 2024 | Wells Fargo | Underweight | Initialise | |
| Aug 06, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Jun 07, 2024 | Evercore ISI | Outperform | Outperform | Hold |
| Jan 04, 2024 | Evercore ISI | Outperform | Upgrade |
Mesa Laboratories's last stock rating was published by Evercore ISI on Oct 01, 2024. The company gave MLAB a "Outperform" rating, the same as its previous rate.
Mesa Laboratories Financial Forecast
Mesa Laboratories Revenue Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $53.47M | $53.16M | $50.65M | $55.59M | $54.29M | $58.75M | $50.45M | $58.88M | $54.70M | $35.84M | $34.92M | $37.96M | $34.17M | $31.86M | $29.94M | $34.21M | $31.66M | $25.54M | $26.29M | $26.45M | $25.14M |
| Avg Forecast | $64.80M | $63.20M | $60.90M | $61.30M | $60.70M | $58.70M | $57.88M | $55.73M | $55.27M | $54.90M | $55.43M | $51.57M | $58.07M | $57.04M | $53.24M | $52.17M | $56.39M | $48.13M | $35.23M | $34.07M | $35.31M | $32.75M | $30.28M | $32.34M | $34.60M | $31.34M | $26.02M | $25.46M | $28.65M | $18.74M |
| High Forecast | $65.64M | $64.02M | $61.69M | $62.09M | $61.49M | $59.46M | $57.99M | $55.73M | $55.27M | $55.00M | $58.93M | $52.23M | $58.82M | $57.78M | $53.98M | $52.90M | $57.17M | $48.80M | $35.71M | $34.54M | $35.79M | $33.20M | $30.70M | $32.78M | $35.08M | $31.77M | $26.38M | $25.81M | $29.05M | $22.48M |
| Low Forecast | $64.27M | $62.69M | $60.40M | $60.80M | $60.21M | $58.22M | $57.76M | $55.73M | $55.27M | $54.80M | $51.93M | $51.15M | $57.60M | $56.58M | $52.51M | $51.46M | $55.62M | $47.48M | $34.74M | $33.60M | $34.82M | $32.30M | $29.87M | $31.89M | $34.13M | $30.91M | $25.66M | $25.11M | $28.26M | $14.99M |
| # Analysts | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.97% | 0.96% | 0.98% | 0.96% | 0.95% | 1.10% | 0.97% | 1.04% | 1.14% | 1.02% | 1.03% | 1.08% | 1.04% | 1.05% | 0.93% | 0.99% | 1.01% | 0.98% | 1.03% | 0.92% | 1.34% |
Mesa Laboratories's average Quarter revenue forecast for Mar 24 based on 1 analysts is $55.27M, with a low forecast of $55.27M, and a high forecast of $55.27M. MLAB's average Quarter revenue forecast represents a 3.35% increase compared to the company's last Quarter revenue of $53.47M (Dec 23).
Mesa Laboratories EBITDA Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| EBITDA | - | - | - | - | - | - | - | - | - | $12.85M | $-60.00K | $-664.00K | $517.00K | $11.66M | $12.65M | $3.74M | $-110.00K | $5.51M | $9.63M | $6.86M | $11.84M | $823.00K | $8.74M | $6.21M | $7.08M | $-217.00K | $5.93M | $7.54M | $4.24M | $6.86M |
| Avg Forecast | $-6.62M | $-6.46M | $-6.23M | $-6.27M | $-6.20M | $-6.00M | $-5.92M | $-5.70M | $22.40M | $-5.61M | $-5.67M | $-5.27M | $23.96M | $3.11M | $3.86M | $3.79M | $25.63M | $3.49M | $2.56M | $6.64M | $2.56M | $2.38M | $2.20M | $9.56M | $2.51M | $2.28M | $1.89M | $5.06M | $2.08M | $4.51M |
| High Forecast | $-6.57M | $-6.41M | $-6.17M | $-6.22M | $-6.15M | $-5.95M | $-5.90M | $-5.70M | $26.89M | $-5.60M | $-5.31M | $-5.23M | $28.75M | $3.73M | $3.92M | $3.84M | $30.75M | $3.54M | $2.59M | $7.97M | $2.60M | $2.41M | $2.23M | $11.47M | $2.55M | $2.31M | $1.91M | $6.07M | $2.11M | $5.41M |
| Low Forecast | $-6.71M | $-6.54M | $-6.31M | $-6.35M | $-6.28M | $-6.08M | $-5.93M | $-5.70M | $17.92M | $-5.62M | $-6.02M | $-5.34M | $19.17M | $2.48M | $3.81M | $3.74M | $20.50M | $3.45M | $2.52M | $5.31M | $2.53M | $2.34M | $2.17M | $7.65M | $2.48M | $2.24M | $1.86M | $4.05M | $2.05M | $3.61M |
| Surprise % | - | - | - | - | - | - | - | - | - | -2.29% | 0.01% | 0.13% | 0.02% | 3.75% | 3.27% | 0.99% | -0.00% | 1.58% | 3.77% | 1.03% | 4.62% | 0.35% | 3.98% | 0.65% | 2.82% | -0.10% | 3.14% | 1.49% | 2.04% | 1.52% |
1 analysts predict MLAB's average Quarter EBITDA for Mar 24 to be $22.40M, with a high of $26.89M and a low of $17.92M. This is 74.34% upper than Mesa Laboratories's previous annual EBITDA (Dec 23) of $12.85M.
Mesa Laboratories Net Income Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| Net Income | - | - | - | - | - | - | - | - | - | $2.12M | $-1.23M | $-937.00K | $611.00K | $451.00K | $1.31M | $-1.44M | $-1.78M | $-2.06M | $3.72M | $2.00M | $3.92M | $-4.54M | $2.68M | $1.02M | $-1.68M | $-4.63M | $3.06M | $4.60M | $1.40M | $4.23M |
| Avg Forecast | $8.59M | $8.59M | $8.37M | $7.99M | $11.31M | $10.47M | $10.34M | $9.68M | $-3.80M | $9.77M | $9.77M | $4.71M | $-4.07M | $-1.16M | $6.58M | $8.00M | $-4.35M | $6.98M | $5.78M | $1.93M | $4.94M | $4.55M | $3.15M | $1.58M | $4.50M | $6.89M | $5.44M | $3.08M | $7.49M | $2.78M |
| High Forecast | $8.73M | $8.73M | $8.51M | $8.12M | $11.50M | $10.64M | $10.35M | $9.85M | $-3.04M | $10.21M | $26.72M | $4.78M | $-3.25M | $-928.20K | $6.74M | $8.14M | $-3.48M | $7.10M | $5.88M | $2.32M | $5.03M | $4.63M | $3.20M | $1.89M | $4.58M | $7.01M | $5.54M | $3.70M | $7.62M | $3.34M |
| Low Forecast | $8.50M | $8.50M | $8.28M | $7.90M | $11.19M | $10.36M | $10.33M | $9.58M | $-4.56M | $9.34M | $-6.52M | $4.66M | $-4.88M | $-1.39M | $6.42M | $7.86M | $-5.22M | $6.85M | $5.67M | $1.54M | $4.85M | $4.47M | $3.09M | $1.26M | $4.42M | $6.77M | $5.35M | $2.47M | $7.35M | $2.23M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.22% | -0.13% | -0.20% | -0.15% | -0.39% | 0.20% | -0.18% | 0.41% | -0.30% | 0.64% | 1.03% | 0.79% | -1.00% | 0.85% | 0.65% | -0.37% | -0.67% | 0.56% | 1.49% | 0.19% | 1.52% |
Mesa Laboratories's average Quarter net income forecast for Mar 24 is $-3.80M, with a range of $-4.56M to $-3.04M. MLAB's average Quarter net income forecast represents a -279.66% decrease compared to the company's last Quarter net income of $2.12M (Dec 23).
Mesa Laboratories SG&A Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| SG&A | - | - | - | - | - | - | - | - | - | $29.18M | $27.18M | $27.04M | $27.68M | $24.57M | $27.40M | $30.23M | $30.04M | $25.98M | $16.33M | $16.28M | $17.68M | $17.93M | $14.40M | $14.17M | $15.38M | $15.67M | $9.98M | $9.73M | $10.98M | $9.49M |
| Avg Forecast | $31.21M | $30.44M | $29.33M | $29.53M | $29.24M | $28.27M | $27.88M | $26.84M | $26.62M | $26.44M | $26.70M | $24.84M | $27.97M | $14.63M | $24.50M | $24.00M | $25.94M | $22.15M | $16.21M | $15.75M | $16.24M | $15.07M | $13.93M | $21.82M | $15.92M | $14.42M | $11.97M | $6.52M | $13.18M | $6.25M |
| High Forecast | $31.62M | $30.83M | $29.71M | $29.91M | $29.62M | $28.64M | $27.93M | $26.84M | $26.62M | $26.49M | $28.39M | $25.16M | $28.33M | $17.56M | $24.83M | $24.34M | $26.30M | $22.45M | $16.43M | $18.90M | $16.47M | $15.28M | $14.13M | $26.18M | $16.14M | $14.62M | $12.13M | $7.83M | $13.37M | $7.50M |
| Low Forecast | $30.96M | $30.19M | $29.09M | $29.29M | $29.00M | $28.04M | $27.82M | $26.84M | $26.62M | $26.40M | $25.01M | $24.64M | $27.74M | $11.70M | $24.16M | $23.68M | $25.59M | $21.84M | $15.98M | $12.60M | $16.02M | $14.86M | $13.74M | $17.46M | $15.70M | $14.22M | $11.81M | $5.22M | $13.00M | $5.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.10% | 1.02% | 1.09% | 0.99% | 1.68% | 1.12% | 1.26% | 1.16% | 1.17% | 1.01% | 1.03% | 1.09% | 1.19% | 1.03% | 0.65% | 0.97% | 1.09% | 0.83% | 1.49% | 0.83% | 1.52% |
Mesa Laboratories's average Quarter SG&A projection for Mar 24 is $26.62M, based on 1 Wall Street analysts, with a range of $26.62M to $26.62M. The forecast indicates a -8.76% fall compared to MLAB last annual SG&A of $29.18M (Dec 23).
Mesa Laboratories EPS Forecast
| Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 5 | 9 | 6 | 4 | 4 | 7 | 4 | 11 |
| EPS | - | - | - | - | - | - | - | - | - | $0.39 | $-0.23 | $-0.17 | $0.11 | $0.08 | $0.25 | $-0.27 | $-0.34 | $-0.39 | $0.71 | $0.39 | $0.76 | $-0.89 | $0.52 | $0.23 | $-0.38 | $-1.06 | $0.74 | $1.18 | $0.36 | $1.11 |
| Avg Forecast | $1.57 | $1.57 | $1.53 | $1.46 | $2.07 | $1.91 | $1.89 | $1.77 | $1.91 | $1.79 | $1.79 | $0.86 | $1.69 | $1.58 | $1.21 | $1.48 | $1.80 | $1.29 | $1.06 | $1.02 | $0.91 | $0.84 | $0.58 | $0.55 | $0.83 | $1.27 | $1.00 | $1.18 | $1.38 | $0.52 |
| High Forecast | $1.60 | $1.60 | $1.56 | $1.48 | $2.10 | $1.95 | $1.89 | $1.80 | $1.91 | $1.87 | $4.88 | $0.87 | $1.71 | $1.61 | $1.24 | $1.50 | $1.83 | $1.31 | $1.08 | $1.02 | $0.93 | $0.85 | $0.59 | $0.56 | $0.84 | $1.29 | $1.02 | $1.20 | $1.40 | $0.62 |
| Low Forecast | $1.55 | $1.55 | $1.51 | $1.44 | $2.04 | $1.89 | $1.89 | $1.75 | $1.91 | $1.71 | $-1.19 | $0.85 | $1.67 | $1.57 | $1.18 | $1.45 | $1.77 | $1.26 | $1.05 | $1.01 | $0.90 | $0.82 | $0.57 | $0.54 | $0.82 | $1.25 | $0.99 | $1.16 | $1.36 | $0.42 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.22% | -0.13% | -0.20% | 0.07% | 0.05% | 0.21% | -0.18% | -0.19% | -0.30% | 0.67% | 0.38% | 0.83% | -1.06% | 0.90% | 0.42% | -0.46% | -0.83% | 0.74% | 1.00% | 0.26% | 2.13% |
According to 1 Wall Street analysts, Mesa Laboratories's projected average Quarter EPS for Mar 24 is $1.91, with a low estimate of $1.91 and a high estimate of $1.91. This represents a 388.89% increase compared to MLAB previous annual EPS of $0.39 (Dec 23).
Mesa Laboratories Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ST | Sensata Technologies | $27.40 | $39.67 | 44.78% | Buy |
| VPG | Vishay Precision Group | $23.06 | $27.00 | 17.09% | |
| FTV | Fortive | $75.00 | $87.33 | 16.44% | Buy |
| ESE | ESCO | $135.68 | $145.00 | 6.87% | Buy |
| COHR | Coherent | $99.78 | $106.29 | 6.52% | Buy |
| BMI | Badger Meter | $220.00 | $221.33 | 0.60% | Hold |
| MLAB | Mesa Laboratories | $131.25 | $120.00 | -8.57% | Buy |
| VNT | Vontier | $36.99 | $32.67 | -11.68% | Buy |
| ITRI | Itron | $110.45 | $89.91 | -18.60% | Buy |